Orange Book product · Generic (ANDA)
BECLOMETHASONE DIPROPIONATE
BECLOMETHASONE DIPROPIONATE
At a glance
Dec 16, 2025
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 16, 2025
6 mo ago
Today
Pharmaceutical detail
Active ingredient
BECLOMETHASONE DIPROPIONATE
Strength
0.04MG/INH
Dosage form
AEROSOL, METERED
Route
INHALATION
TE code
Not listed
Application
ANDA 213811
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of BECLOMETHASONE DIPROPIONATE
- 2017QVAR REDIHALERBrand (NDA)
NDA 207921 · NORTON WATERFORD
- 2014QNASLBrand (NDA)
NDA 202813 · TEVA BRANDED PHARM
- 2000QVAR 40Brand (NDA)
NDA 020911 · TEVA BRANDED PHARM
- 1996VANCERIL DOUBLE STRENGTHBrand (NDA)
NDA 020486 · SCHERING
- —BECLOVENTBrand (NDA)
NDA 018153 · GLAXOSMITHKLINE
- —VANCERILBrand (NDA)
NDA 017573 · SCHERING
- —BECONASEBrand (NDA)
NDA 018584 · GLAXOSMITHKLINE
- —VANCENASEBrand (NDA)
NDA 018521 · SCHERING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
